Clinical trial
Treatment of Oral Warts in HIV+ Patients
NCT00454181 · Ainos, Inc. (f/k/a Amarillo Biosciences Inc., Industry · Completed
Key facts
| NCT number | NCT00454181 |
|---|---|
| Title | Treatment of Oral Warts in HIV+ Patients |
| Official title | Evaluation of Natural Human Interferon Alpha Administered Oromucosally in the Treatment of Oral Warts in HIV-seropositive Subjects Receiving Combination Anti-retroviral Therapy: A Phase 2 Clinical Trial |
| Lead sponsor | Ainos, Inc. (f/k/a Amarillo Biosciences Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Papillomatosis, HIV Infections |
| Intervention type | Drug, Other |
| Interventions | Interferon-alpha, placebo |
| Enrollment | 59 |
| Start date | Feb 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Mar 30, 2007 |
| Last update posted | Sep 16, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: